晚期浆液性上皮性卵巢癌腹膜病灶与原发肿瘤标准化摄取值比值的预后价值
回顾性分析97例FIGO III–IV期浆液性上皮性卵巢癌患者的术前[18F]FDG PET/CT,评估转移灶与原发肿瘤SUV比值对复发的预测价值。多因素分析显示高龄(p=0.035,HR 1.032,95%CI 1.002–1.062)和高SUVperit/SUVovary(p=0.046,HR 1.755,95%CI 1.011–3.047)是复发的独立危险因素,按该比值分组患者无进展生存期有显著差异(Log-Rank检验,p=0.001)。
要点
- 术前PET/CT测得的高SUVperit/SUVovary是晚期浆液性EOC复发的独立危险因素(p=0.046,HR 1.755)。
- 按SUVperit/SUVovary分组患者无进展生存期存在显著差异(Log-Rank检验,p=0.001)。
- 该比值可为预测复发提供增量性能。
核心结论
- 在晚期浆液性上皮性卵巢癌患者中,术前[18F]FDG PET/CT测量的SUVperit/SUVovary对预测复发提供显著的增量性能。
研究设计与样本
- 回顾性研究,纳入97例FIGO III、IV期浆液性上皮性卵巢癌患者,术前接受[18F]FDG PET/CT扫描,评估临床病理变量及PET/CT参数(SUVovary、SUVLN、SUVperit、SUVdist及转移灶与原发肿瘤SUV比值)。
诊断标准与关键数值
- 中位无进展生存期为18个月(范围6–90个月),59例(60.8%)患者出现复发。
- 多因素回归分析中,高龄为复发的独立危险因素(p=0.035,HR 1.032,95%CI 1.002–1.062)。
- 多因素回归分析中,高SUVperit/SUVovary为复发的独立危险因素(p=0.046,HR 1.755,95%CI 1.011–3.047)。
- 按SUVperit/SUVovary分组的患者无进展生存期有显著差异(Log-Rank检验,p=0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Using preoperative PET/CT, we evaluated the prognostic value of preoperative [18F]FDG uptake ratio between various metastatic lesions and primary tumour in patients with advanced serous epithelial ovarian cancer (EOC).
METHODS: We retrospectively reviewed patients with International Federation of Gynecology and Obstetrics (FIGO) stage III, IV serous EOC who underwent preoperative [18F]FDG PET/CT scans. Clinico-pathological variables and PET/CT parameters such as maximum standardized uptake value of the ovarian cancer (SUVovary), pelvic or para-aortic LN (SUVLN), peritoneal (SUVperit) and distant extra-peritoneal (SUVdist) metastatic lesions, and the metastatic lesion-to-ovarian cancer standardized uptake value ratio were assessed.
RESULTS: Clinico-pathological data were retrospectively reviewed for 97 eligible patients. The median progression-free survival (PFS) was 18 months (range, 6-90 months) and 59 (60.8 %) patients experienced recurrence. In multivariate regression analysis, older age (p = 0.035, hazard ratio (HR) 1.032, 95 % CI 1.002-1.062), and high SUVperit/SUVovary (p = 0.046, HR 1.755, 95 % CI 1.011-3.047) were independent risk factors of recurrence. Patient group categorized by SUVperit/SUVovary showed significant difference in PFS (Log-Rank test, p = 0.001).
CONCLUSIONS: In patients with advanced serous EOC, preoperative SUVperit/SUVovary measured by [18F]FDG PET/CT provides significant incremental performance for prediction of recurrence.
KEY POINTS: • PET/CT data from advanced serous epithelial ovarian cancer patients were analysed. • Prognostic value of SUV ratio between metastatic and primary tumour was investigated. • SUV perit /SUV ovary provides incremental performance for prediction of recurrence.
引用
- Chung HH, Kim JW, Park NH, et al. Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer. Eur Radiol. 2017. PMID: 29260365. doi:10.1007/s00330-017-5194-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。